Science & Technology Watch

  • GAFAM : les bienfaiteurs insolites de la biomédecine

    Trois milliards de dollars. C’est le montant que Priscilla Chan et son mari, Marc Zuckerberg, ont annoncé être sur le point d’investir dans la recherche biomédicale. L’objectif : éliminer, guérir ou prévenir les principales maladies qui touchent l’espèce humaine d’ici à la fin du siècle.

  • Revue de Presse Sciences de la Vie - Septembre 2016

    Retrouvez ici une sélection d’articles issus de notre veille quotidienne aux Etats-Unis pour la période du 1er au 30 septembre 2016. Au sommaire de ce numéro : Psoriasis / Règlementation des cellules souches / Cancer Moonshot Initiative / Edition du génome / Prix lasker / Zika….


Calls for Proposals

  • IMéRA calls for applications 2017-2018

    IMéRA is an Institute for Advanced Study of the Aix-Marseille University, a unique research center where both emerging and top-level scientists can take advantage of residence schemes to carry out (...)
  • FACCTS: 2017 Call for proposals

    The France And Chicago Collaborating in The Sciences (FACCTS) program is designed to enhance science at the University of Chicago by encouraging closer relations between researchers in Physics (...)
  • France-Stanford: 2017-2018 Call for Proposals

    The France-Stanford Center for Interdisciplinary Studies, founded in partnership with the French Ministry of Foreign Affairs, aims to bridge the disciplines of the Humanities, Social Sciences, (...)
More calls for proposals
Choose your location
San Francisco Houston Atlanta Chicago Washington Boston Los Angeles
Sector: Life Sciences

The Life Sciences and Health sectors represent important strategic international stakes in terms of economic and social issues. In this sector, the United States occupies a more and more preponderant position. Biology research in the U.S. is mostly concentrated in "clusters" built around leading academic and research institutions (Boston, Philadelphia, San Diego, San Francisco, ..). These clusters attract 60% of funding from the NIH (National Institutes of Health) for research, 67% of biotechnology patents, 95% of investments in partnerships and 75% of biotech companies with over 100 employees. Read more


Attaché for Science and Technology
(310) 235-3248

Gabrielle MERITE

Deputy Attaché for Science and Technology
(310) 235-3212


Deputy Attaché for Science and Technology
(404) 495-1699

Mireille GUYADER

Delegate, INSERM
(202) 944-6253

Follow us
Subscribe to our Newsletters